# Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men

> **NCT00856323** · PHASE2 · COMPLETED · sponsor: **Friends Research Institute, Inc.** · enrollment: 53 (actual)

## Conditions studied

- Amphetamine-Related Disorders
- HIV
- HIV Infections

## Interventions

- **DRUG:** Truvada
- **BEHAVIORAL:** CM

## Key facts

- **NCT ID:** NCT00856323
- **Lead sponsor:** Friends Research Institute, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2016-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856323, "Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00856323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*